Cancer Detection and Diagnosis Research in New Jersey
Cancer Detection and Diagnosis Research (93.394) awarded $18.7 million to recipients in New Jersey in 15 grants from fiscal 2021 to 2025, 0.7% of the program's national total. Rutgers the State University of New Jersey received the most, $11.3 million.
- Awarded in New Jersey$18.7 million
- Awards15
- Share of the program0.7%
- Rank among states26th of 45
- National total$2.7 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 9 | $5.0 million |
| FY 2022 | 9 | $5.6 million |
| FY 2023 | 7 | $4.0 million |
| FY 2024 | 6 | $2.5 million |
| FY 2025 | 4 | $1.7 million |
Recipients in New Jersey
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| Rutgers the State University of New Jersey | Colleges and universities | 6 | $11.3 million |
| Visikol Inc | Small businesses | 1 | $1.6 million |
| Cellectar Biosciences, Inc | Small businesses | 1 | $1.6 million |
| Rutgers, the State University | Colleges and universities | 2 | $1.5 million |
| Rutgers, the State University | Colleges and universities | 2 | $1.0 million |
| The Trustees of Princeton University | Colleges and universities | 1 | $899,875 |
| Rutgers, the State University of New Jersey | Colleges and universities | 1 | $480,695 |
| Pre-Cancer Diagnosis, LLC | Small businesses | 1 | $398,738 |
Open opportunities under this program
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)
- Competing Revisions to Existing NIH Single Project Research Grants and Cooperative Agreements (Clinical Trial Optional)
- Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)
- Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional)
- National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)
- Glioblastoma Therapeutics Network (GTN) (U19 Clinical Trial Required)
- Limited Competition: Biospecimen Banks to support NCI National Clinical Trials Network Biospecimen Banks (NCTN Biobanks) and the NCI Early-Phase and Experimental Clinical Trials Biospecimen Bank (EET Biobank) (U24 Clinical Trial Not Allowed)
- NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
- NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional)
See all 50 on the program page
Questions people ask
How much Cancer Detection and Diagnosis Research money goes to New Jersey?
$18.7 million from fiscal 2021 to 2025, across 15 awards. New Jersey ranks 26th of 45 states and territories for this program.
Who receives Cancer Detection and Diagnosis Research money in New Jersey?
The largest recipient is Rutgers the State University of New Jersey, with $11.3 million in 6 awards. Next are Visikol Inc and Cellectar Biosciences, Inc.
Can organizations in New Jersey apply now?
Yes, 50 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
Cancer Detection and Diagnosis Research in other states
Other large programs in New Jersey
- Grants to States for Medicaid
- Highway Planning and Construction
- Education Stabilization Fund
- Federal Transit Formula Grants
- Disaster Grants - Public Assistance (Presidentially Declared Disasters)
- National School Lunch Program
- Children's Health Insurance Program
- Special Education Grants to States
- 1332 State Innovation Waivers
- Title I Grants to Local Educational Agencies